Controlling extensively drug-resistant tuberculosis

Lancet

Volumn 370, Issue 9597, 2007, Pages 1464-1465

  Porco, Travis C ^a   Getz, Wayne M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ACCURACY; ARTICLE; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL MODEL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RURAL AREA; SHORT COURSE THERAPY; SOUTH AFRICA; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 35448994752     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61614-6     Document Type: Note

References (13)

1. WHO. Global tuberculosis control-surveillance, planning, financing (2007). http://www.who.int/tb/publications/global_report/2007/en/index.html (accessed Sept 3, 2007).
2. Stop TB Partnership and WHO. Global Plan to Stop TB 2006-2015 (2006), World Health Organization, Geneva. http://www.who.int/tb/publications/global_plan_to_stop_tb/en/index.html (accessed Sept 3, 2007).
3. Rich M. Diagnosis and treatment of multidrug-resistant tuberculosis. In: Raviglione M. (Ed). Reichman and Hershfield's tuberculosis: a comprehensive international approach. 3rd edn. (2006), Informa Healthcare, New York 417-458
4. Shah N., Wright A., Bai G., et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 13 (2007) 380-387
5. Gandhi N., Moll A., Sturm A., et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368 (2006) 1575-1580
6. Basu S., Andrews J., Poolman E., et al. The impact of preventing nosocomial transmission of extensively drug-resistant (XDR) tuberculosis in rural South African district hospitals. Lancet 370 (2007) 1500-1507
7. WHO. WHO Guidance on human rights and involuntary detention for XDR-TB control (Jan 24, 2007). http://www.who.int/tb/xdr/involuntary_treatment/en/index.html (accessed Aug 20, 2007).
8. Lloyd-Smith J., Schreiber S., Kopp P., and Getz W. Superspreading and the effect of individual variation on disease. Nature 438 (2005) 355-359
9. Porco T., Lewis B., Marseille E., et al. Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants. BMC Public Health 6 (2006) 157
10. Mann T. The magic mountain (1996), Vintage, New York
11. Oliver P. Conversation with the Blues (1997), Cambridge University Press, Cambridge
12. WHO. The global MDR-TB and XDR-TB response plan 2007-2008 (2007). http://www.stoptb.org/resource_center/assets/documents/Global%20MDR-TB_and_%20XDR-TB_Response%20Plan_2007-08.pdf (accessed Sept 3, 2007).
13. Singh J., Upshur R., and Padayatchi N. XDR-TB in South Africa: no time for denial or complacency. PLoS Med 4 (2007) e50